TickerFactsScreenerDevelopers

CORCEPT THERAPEUTICS INC (CORT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $14.72M2009: $23.87M2010: $24.58M2011: $39.63M2012: $93.03M2013: $54.88M2014: $24.25M2015: $40.44M2016: $51.54M2017: $31.06M2018: $41.62M2019: $31.27M2020: $76.19M2021: $77.62M2022: $66.33M2023: $135.55M2024: $127.67M2025: $120.50M$120.50M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$120.50M-5.6%
2024$127.67M-5.8%
2023$135.55M+104.4%
2022$66.33M-14.5%
2021$77.62M+1.9%
2020$76.19M+143.7%
2019$31.27M-24.9%
2018$41.62M+34.0%
2017$31.06M-39.7%
2016$51.54M+27.5%
2015$40.44M+66.8%
2014$24.25M-55.8%
2013$54.88M-41.0%
2012$93.03M+134.7%
2011$39.63M+61.3%
2010$24.58M+3.0%
2009$23.87M+62.2%
2008$14.72M—